ANTIHUMAN LAT1 MONOCLONAL ANTIBODY, AND KIT FOR DECIDING DEGREE OF MALIGNANCY IN PROSTATE CANCER

摘要

PROBLEM TO BE SOLVED: To provide a means of a molecular marker as a novel diagnosis method in addition to the Gleasons classification and the TMN classification.

SOLUTION: The means can determine the malignancy of the prostatic cancer highly accurately and easily even in the case of using not a material ablated in an operation but a material sampled in a cytodiagnosis test by combining the Gleasons classification using a biopsy material in an early stage before the operation. A deciding kit and a deciding method for the prognosis of a patient by deciding (diagnose) the malignancy of the prostatic cancer are provided.

COPYRIGHT: (C)2013,JPO&INPIT